BamSEC and AlphaSense Join Forces
Learn More

LENZ Therapeutics Inc. – Indentures

NASDAQ: LENZ    
Share price (5/22/26): $7.55    
Market cap (5/22/26): $237 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from S-3 49 pages LENZ Therapeutics, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.4
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-4 9 pages Presbyopia Therapies, Inc. Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.5
from S-4 9 pages Presbyopia Therapies, Inc. Warrant to Purchase Shares of Series a Preferred Stock
12/34/56
EX-4.4
from S-4 15 pages Amended and Restated By-Laws of Lenz Therapeutics, Inc. (A Delaware Corporation) Adopted by the Sole Incorporator on October 28, 2020 Affirmed by the Board of Directors on October 30, 2020 Amended and Restated on March 1, 2023 Amended and Restated By-Laws of Lenz Therapeutics, Inc. Article 1.- Stockholders
12/34/56
EX-4.3
from S-4 31 pages Amended and Restated Certificate of Incorporation of Lenz Therapeutics, Inc
12/34/56
EX-4.5
from S-3 37 pages Graphite Bio, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 35 pages Graphite Bio, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.3
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 71 pages Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.2
from DRS/A 71 pages Amended and Restated Investors’ Rights Agreement
12/34/56